A previous study reported that the percentage of cells coexpressing CD105 + /CD73 + /CD90 + in glioma tumor samples inversely correlates with patient overall survival [16]; however, some limitations and deficiencies should be addressed. This evidence concerns the gene THY1 and central nervous system cancer.